The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Impact of post-dilation on the acute and one-year clinical outcomes of a large cohort of patients treated solely with the Absorb Bioresorbable Vascular Scaffold
EuroIntervention 2015;11:141-148 published online ahead of print May 2015. DOI: 10.4244/EIJY15M05_06
José De Ribamar Costa Jr1*, MD, PhD; Alexandre Abizaid1, MD, PhD; Antonio L. Bartorelli2, MD; Robert Whitbourn3, MD; Robert Jan van Geuns4, MD, PhD; Bernard Chevalier5, MD; Marcos Perin6, MD, PhD; Ashok Seth7, MD; Roberto Botelho8, MD, PhD; Patrick W. Serruys4, MD, PhD; on behalf of the ABSORB EXTEND Investigators
1. Instituto de Cardiologia Dante Pazzanese, São Paulo, Brazil; 2. Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy; 3. St Vincent’s Hospital, Fitzroy, Victoria, Australia; 4. Thoraxcenter, Erasmus University Medical Center, Rotterdam
Aims: We sought to determine the impact of post-dilation (PD) on clinical outcomes in a large cohort of patients treated only with the Absorb Bioresorbable Vascular Scaffold (BVS).